Serke S, Beyer J, Rick O, Schwella N, Meyer O, Hildebrandt M, Huhn D
Department of Haematology-Oncology, Campus Virchow Hospital Charite, Humboldt University, Berlin, Germany.
Vox Sang. 1998;74 Suppl 2:469-75. doi: 10.1111/j.1423-0410.1998.tb05459.x.
The flow cytometric determination of haemopoietic cells defined as CD34-expressing cells has greatly added to the improvement of the management of harvesting circulating haemopoietic cells for subsequent autologous reinfusion in the setting of high-dose chemo/(radio)-therapy. Additionally, this flow cytometric determination has replaced, in some institutions, the in-vitro culture test for CFU-GM as the measure to estimate the haemopoietic potential of the cells to be reinfused/transplanted.
通过流式细胞术测定定义为表达CD34的造血细胞,极大地促进了采集循环造血细胞管理的改进,以便在大剂量化疗/(放疗)情况下随后进行自体回输。此外,在一些机构中,这种流式细胞术测定已取代了CFU-GM的体外培养试验,作为评估待回输/移植细胞造血潜力的方法。